Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Efficacité de la NMES transcutanée comme traitement d'appoint pour les troubles de la déglutition chez les patients trachéotomisés (SWALEC)

18 septembre 2026 mis à jour par: Hopital Forcilles

Évaluation de l'efficacité de la stimulation électrique neuromusculaire transcutanée comme traitement adjuvant au traitement standard des troubles de la déglutition chez les patients trachéotomisés après un sevrage prolongé de la ventilation mécanique

Dysphagia can reach a prevalence of up to 80% in intensive care patients. The implementation or prolonged presence of medical devices such as the intubation tube, tracheostomy, or nasogastric tube alters the physiology of swallowing and causes local injuries at several levels. Additionally, certain medical treatments impair swallowing physiology and the patient's alertness, further promoting the development of these disorders.

Management of dysphagia involves two main types of strategies: adaptive or compensatory maneuvers and rehabilitation techniques such as: performing praxis or swallowing exercises; physical stimulation (tactile or thermal); transcranial stimulation (electrical or magnetic); and finally, pharyngeal or transcutaneous electrical stimulation (NMES).

Patients hospitalized in intensive care often present with altered levels of alertness, asynchronous ventilation and swallowing, and reduced motor capabilities, making it difficult to perform techniques like praxis, food trials, or resistance swallowing exercises. NMES does not require active patient cooperation or the permanent presence of the therapist during the stimulation session, thus increasing the intensity of dysphagia rehabilitation and the early implementation of treatment in these patients, complementing conventional rehabilitation. Muscle and sensory stimulation through the application of NMES can help increase the strength of the muscles involved in swallowing and improve sensory capabilities. However, its effects have not yet been evaluated in tracheostomized patients undergoing weaning from prolonged mechanical ventilation.

Aperçu de l'étude

Statut

Pas encore de recrutement

Les conditions

Intervention / Traitement

Type d'étude

Interventionnel

Inscription (Estimé)

238

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Sauvegarde des contacts de l'étude

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans et plus (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • Hospitalized in intensive care units, post-ICU rehabilitation, or weaning and rehabilitation services;
  • Presence of a tracheostomy for more than 72 hours due to difficult mechanical ventilation weaning;
  • Diagnosis of swallowing disorders (swallowing fiberoscopy);
  • Patient aged at least 18 years at the time of inclusion;
  • Affiliated to a social security scheme or beneficiary of such a scheme;
  • Written, free and informed consent of the patient or their next of kin.

Exclusion Criteria:

  • Contra- indication to cervical NMES;
  • History of swallowing disorders;
  • Patient with a spinal cord injury above C5 level;
  • History of head and neck cancer;
  • Person under legal protection measures;
  • Patient under guardianship or conservatorship;
  • Known pregnancy;
  • Limitation of care.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Double

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Comparateur placebo: Placebo Neuromuscular Electrical Stimulation (Placebo NMES)

Patients included in the control group will receive standard care and the control intervention. The Neuro Muscular Electrical Stimulation (NMES) will be applied through 2 pairs of electrodes to the anterior surface of the neck. The same frequency and pulse duration will be used. The intensity will be increased until a vibration/tingling sensation perceptible by the patient is produced. The device will then be turned off.

NMES will be applied via two pairs of electrodes on the anterior neck.

Two electrodes will be placed above the hyoid bone, on either side, between the hyoid bone and the mandible. The other two electrodes will be placed on either side of the thyroid cartilage.

The patient will also be comfortably positioned in a supine position, with the backrest inclined at 45°. The same frequency and pulse duration will be used. The intensity will be increased until the patient perceives a vibrating/tingling sensation. The device will then be turned off.

The control intervention begins at least 72 hours after the tracheotomy and lasts for 21 days, with daily 30-minute sessions, five days per week.

The treatment is administered once per day at a time slot chosen by each center.

Expérimental: Neuromuscular Electrical Stimulation (NMES)

The patient is comfortably positioned on their back, with the backrest at a 45° incline. Neuromuscular electrical stimulation (NMES) is applied through two pairs of electrodes placed on the front of the neck: one pair on the supra-hyoid muscles and the other on the infra-hyoid muscles. The electrodes are positioned using anatomical landmarks of the hyoid bone and the mandible. A current of 80 Hz with a pulse duration of 700 µs is applied to induce a muscle contraction. The treatment begins at least 72 hours after the tracheotomy and lasts for 21 days, with daily 30-minute sessions, 5 days a week. The treatment is performed once per day.

Let me know if you need further adjustments or explanations!

The patient will be comfortably positioned on their back, with the backrest inclined at 45°.

NMES will be applied via two pairs of electrodes on the anterior neck. One pair of electrodes will be placed on the suprahyoid muscles and the other on the infrahyoid muscles.

The treatment begins at least 72 hours after the tracheotomy and lasts for 21 days, with daily 30-minute sessions, five days per week. The treatment is administered once per day. Each department is encouraged to identify a time slot to facilitate the organization of care and avoid non-completion of the treatment.

The duration of the session and the frequency of the intervention's application were chosen based on data from a recent systematic review of randomized controlled trials comparing the effectiveness of NMES versus conventional treatment. The included studies mostly had session durations around 30 minutes, 2 to 5 times per week, for a period of 2 to 6 weeks.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Prevalence of swallowing disorders after 21 days of NMES of the suprahyoid and infrahyoid muscles as an adjunct to standard treatments, in patients following tracheotomy due to prolonged mechanical ventilation weaning
Délai: after 21 days of treatment

Evaluate the effectiveness of NMES of the suprahyoid and infrahyoid muscles as an adjunct to standard treatments for swallowing disorders, on the prevalence of these disorders after 21 days of treatment, in patients who have undergone tracheotomy due to prolonged mechanical ventilation weaning.

after 21 days of treatment

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Severity of swallowing disorders - the yale pharyngeal residue severity rating scale
Délai: 21 days

Comparatively evaluate the effectiveness of NMES of the suprahyoid and infrahyoid muscles as an adjunct to standard treatments for swallowing disorders in patients who have undergone tracheotomy due to prolonged mechanical ventilation weaning on the severity of swallowing disorders at 21 days of NMES as an adjunct to standard treatments, in patients following tracheotomy. Unit of Measure: the yale pharyngeal residue severity rating scale rated by a speech-language therapist based on fiberoptic endoscopic evaluation of swallowing (FEES). This assessments by a speech-language therapist blinded to group allocation.

21 days
Time to resume oral feeding at Day 21 after NMES initiation
Délai: At day 21 after initiation of NMES/placebo

Description:

Comparative evaluation of the effectiveness of neuromuscular electrical stimulation (NMES) of the suprahyoid and infrahyoid muscles, as an adjunct to standard care, on time to resume oral feeding within 21 days in tracheotomized patients following prolonged mechanical ventilation weaning. Time will be measured in days. In routine practice, all changes in the patient's dietary intake are recorded daily by medical, dietitians and nursing staff. Data collected from the patient's electronic medical record by a clinical research technician.

At day 21 after initiation of NMES/placebo
Duration of mechanical ventilation
Délai: Day 21 after initiation of NMES treatment/placebo

Comparative evaluation of the effectiveness of neuromuscular electrical stimulation (NMES) of the suprahyoid and infrahyoid muscles, as an adjunct to standard care, on the duration of mechanical ventilation. Data collected from the patient's electronic medical record by a clinical research technician.

Day 21 after initiation of NMES treatment/placebo
Lenght of stay
Délai: From study inclusion (Day 0) until discharge from the intensive care unit or post-intensive care unit, assessed up to study completion (approximately 30 days)

Comparative evaluation of the effectiveness of neuromuscular electrical stimulation (NMES) of the suprahyoid and infrahyoid muscles, as an adjunct to standard care, on length of stay in the intensive care unit. Length of stay will be measured in days and collected from the electronic medical records by a trained clinical research technician.

From study inclusion (Day 0) until discharge from the intensive care unit or post-intensive care unit, assessed up to study completion (approximately 30 days)
Time to tracheostomy decannulation
Délai: From study inclusion (Day 0) until tracheostomy decannulation, assessed up to study completion (approximately 30 days)

Comparative evaluation of the effectiveness of neuromuscular electrical stimulation (NMES) of the suprahyoid and infrahyoid muscles, as an adjunct to standard care, on time to tracheotomy decannulation. Time will be measured in days. Data will be collected from the electronic medical records by a trained clinical research technician.

From study inclusion (Day 0) until tracheostomy decannulation, assessed up to study completion (approximately 30 days)
Prevalence of malnutrition
Délai: At day 21 after initiation NMES treament/place

Comparative evaluation of the effectiveness of neuromuscular electrical stimulation (NMES) of the suprahyoid and infrahyoid muscles, as an adjunct to standard care, on the prevalence of malnutrition at Day 21. Prevalence of malnutrition will be expressed as a percentage of patients meeting predefined diagnostic criteria (French national recommendations on malnutrition diagnostic evaluation)

At day 21 after initiation NMES treament/place
Prevalence of malnutrition at unit discharge
Délai: At study end, defined as discharge from the intensive care unit or post-intensive care unit, assessed up to study completion (approximately 30 days)

Comparative evaluation of the effectiveness of neuromuscular electrical stimulation (NMES) of the suprahyoid and infrahyoid muscles, as an adjunct to standard care, on the prevalence of malnutrition at unit discharge. Prevalence of malnutrition will be expressed as a percentage of patients meeting predefined diagnostic criteria (French national recommendations on malnutrition diagnostic evaluation)

At study end, defined as discharge from the intensive care unit or post-intensive care unit, assessed up to study completion (approximately 30 days)

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Parrainer

Les enquêteurs

  • Chercheur principal: Carlos Diaz Lopez, Hopital Forcilles

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Estimé)

1 octobre 2026

Achèvement primaire (Estimé)

1 juin 2028

Achèvement de l'étude (Estimé)

30 juin 2028

Dates d'inscription aux études

Première soumission

13 janvier 2026

Première soumission répondant aux critères de contrôle qualité

9 avril 2026

Première publication (Réel)

14 avril 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

21 septembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

18 septembre 2026

Dernière vérification

1 septembre 2026

Plus d'information

Termes liés à cette étude

Mots clés

Autres numéros d'identification d'étude

  • 2024-A01576-41

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .